Trial Profile
A study to generate multiple-dose PK and safety data of IV brincidofovir (BCV) in virally infected patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 May 2017
Price :
$35
*
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections; Cytomegalovirus infections; Smallpox; Viral infections
- Focus Adverse reactions
- 17 May 2017 New trial record